A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease

NCT00165672 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-erosive Gastroesophageal Reflux Disease

Interventions

DRUG: RABEPRAZOLE SODIUM
DRUG: RABEPRAZOLE SODIUM

Sponsor

Eisai Inc.

Collaborators

[object Object]